Appointment of Independent Non-executive Director | 20-Nov-2024 | 09:30 | RNS |
Total Voting Rights | 31-Oct-2024 | 08:30 | RNS |
Vesting of awards under the LTIP | 21-Oct-2024 | 09:30 | RNS |
SAVANNAH: clinically meaningful response rate | 16-Oct-2024 | 07:00 | RNS |
Japan Approval for FRUZAQLA | 24-Sep-2024 | 08:00 | RNS |
Total Voting Rights | 30-Aug-2024 | 09:30 | RNS |
Update on Fruquintinib for Gastric Cancer in China | 30-Aug-2024 | 07:00 | RNS |
Standard form for notification of major holdings | 22-Aug-2024 | 09:30 | RNS |
LTIP and Share Option Scheme | 06-Aug-2024 | 10:00 | RNS |
2024 Interim Results and Business Updates | 31-Jul-2024 | 12:00 | RNS |
Total Voting Rights | 28-Jun-2024 | 09:30 | RNS |
Blocklisting Six Monthly Return | 28-Jun-2024 | 09:30 | RNS |
HUTCHMED to Announce 2024 HY Financial Results | 26-Jun-2024 | 09:30 | RNS |
European Commission Approval for FRUZAQLA | 24-Jun-2024 | 07:00 | RNS |
Total Voting Rights | 31-May-2024 | 09:30 | RNS |
Currency | UK Pounds |
Share Price | 281.00p |
Change Today | -3.00p |
% Change | -1.06 % |
52 Week High | 352.00p |
52 Week Low | 192.40p |
Volume | 30,671 |
Shares Issued | 871.56m |
Market Cap | £2,449.09m |
Beta | 1.20 |
RiskGrade | 226 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:15 | 175 @ 281.88p |
16:12 | 154 @ 281.00p |
16:12 | 125 @ 281.00p |
16:12 | 475 @ 281.00p |
16:12 | 436 @ 281.00p |
You are here: research